Stock listing

NASDAQ:TSHA Taysha Gene Therapies, Inc. Stock

Home listing (NASDAQ) of Taysha Gene Therapies, Inc.

Follow Taysha Gene Therapies, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:TSHA

$4.33 USD +0.24 (+5.9%)

Close on Nov 6, 2026

Past year +10.5% · daily closes, Nov 6, 2025 – Nov 6, 2026, adjusted for splits
Day range
$4.14 – $4.44 USDNov 6, 2026
Volume
3.18M sharesNov 6, 2026
Market cap
$1.41B USDAt the close on Nov 6, 2026 · price × 325.8M shares outstanding
52-week range
$3.46 – $7.30 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
Traded on an average day
$17.41M USDMedian day 3.08M shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Taysha Gene Therapies, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TSHA · Home$4.33 USD+0.24 (+5.9%)3,182,465$4.16$4.44$4.139$4.09Close on Nov 6, 2026

Daily closes

Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:TSHA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.33+0.24+5.9%$4.16$4.44$4.1393,182,465
$4.09-0.27-6.2%$4.38$4.40$4.006,742,778
$4.36+0.27+6.6%$4.08$4.38$4.0053,678,729
$4.09+0.09+2.2%$4.05$4.16$3.921,721,939
$4.00-0.13-3.1%$4.17$4.195$3.952,007,821
$4.13-0.09-2.1%$4.18$4.25$4.071,500,817
$4.22-0.01-0.2%$4.225$4.47$4.1452,056,466
$4.23-0.02-0.5%$4.24$4.28$4.123,318,687
$4.25+0.24+6.0%$4.04$4.27$3.972,798,314
$4.01+0.05+1.3%$3.98$4.09$3.951,698,826
$3.96-0.045-1.1%$3.95$3.98$3.7552,592,900
$4.005-0.115-2.8%$4.07$4.175$3.9353,105,100
$4.12+0.01+0.2%$4.15$4.265$4.053,511,200
$4.11+0.17+4.3%$3.95$4.20$3.8910,925,700
$3.94+0.32+8.8%$3.66$3.965$3.655,816,800
$3.62-0.11-2.9%$3.73$3.745$3.602,751,800
$3.73+0.22+6.3%$3.53$3.79$3.504,685,200
$3.51-0.07-2.0%$3.51$3.715$3.4554,342,700
$3.58-0.56-13.5%$4.09$4.13$3.556,115,200
$4.14-0.35-7.8%$4.46$4.56$4.1254,214,100
$4.49+0.06+1.4%$4.42$4.565$4.365,382,800
$4.430.000.0%$4.37$4.455$4.3253,914,600
$4.43+0.04+0.9%$4.33$4.46$4.263,912,400
$4.39-0.10-2.2%$4.51$4.57$4.264,833,700
$4.49-0.14-3.0%$4.64$4.64$4.374,974,800
$4.63-0.11-2.3%$4.80$4.86$4.632,990,200
$4.74-0.13-2.7%$4.86$4.935$4.733,847,100
$4.87-0.12-2.4%$5.03$5.03$4.823,901,500
$4.990.000.0%$4.97$5.03$4.806,570,200
$4.99+0.32+6.9%$4.64$5.055$4.566,262,500
$4.67-0.12-2.5%$4.88$4.88$4.6654,660,800
$4.79-0.12-2.4%$4.88$4.90$4.6556,404,400
$4.91-0.25-4.8%$5.11$5.14$4.885,507,300
$5.16+0.12+2.4%$5.11$5.215$5.0822,305,400
$5.04+0.02+0.4%$5.07$5.124$4.9951,676,200
$5.02-0.14-2.7%$5.16$5.28$4.969,116,700
$5.16+0.09+1.8%$5.25$5.46$5.054,082,200
$5.07+0.01+0.2%$5.08$5.135$4.9754,346,900
$5.06+0.05+1.0%$5.00$5.19$4.905,148,800
$5.01-0.01-0.2%$5.00$5.12$4.986,695,900
$5.02-0.14-2.7%$5.26$5.28$4.981,777,300
$5.16-0.18-3.4%$5.24$5.24$5.012,402,900
$5.34-0.14-2.6%$5.40$5.485$5.2851,810,200
$5.48-0.12-2.1%$5.57$5.575$5.402,222,100
$5.60+0.03+0.5%$5.52$5.61$5.422,111,200
$5.57-0.07-1.2%$5.62$5.665$5.501,878,100
$5.64-0.06-1.1%$5.73$5.96$5.551,988,300
$5.70+0.01+0.2%$5.645$5.77$5.561,763,200
$5.69-0.08-1.4%$5.70$5.775$5.5352,062,800
$5.77-0.19-3.2%$5.89$5.915$5.6252,070,900
$5.96-0.06-1.0%$5.99$6.09$5.892,187,200
$6.02-0.18-2.9%$6.15$6.27$5.911,281,300
$6.20+0.23+3.9%$5.99$6.27$5.991,690,600
$5.97-0.12-2.0%$6.02$6.075$5.8252,588,500
$6.09-0.02-0.3%$6.18$6.24$6.0152,831,000
$6.11-0.32-5.0%$6.04$6.30$5.923,396,600
$6.43+0.24+3.9%$6.40$6.52$6.294,280,300
$6.19-0.02-0.3%$6.08$6.275$6.031,631,600
$6.21+0.26+4.4%$5.93$6.27$5.823,050,800
$5.95-0.04-0.7%$5.90$6.006$5.7162,131,900
$5.99-0.415-6.5%$6.40$6.40$5.942,184,600
$6.405-0.275-4.1%$6.13$6.449$6.013,913,800
$6.68+0.31+4.9%$6.42$6.75$6.284,986,800
$6.37-0.19-2.9%$6.48$6.60$6.2182,240,400
$6.56+0.22+3.5%$6.45$6.57$6.351,929,600
$6.34-0.12-1.9%$6.39$6.55$6.282,106,100
Ticker
NASDAQ:TSHA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Upcoming

  • Taysha Gene Therapies (NASDAQ:TSHA) Q3 2026 Earnings Call

    Thu, Nov 12, 2026 · 8:30 AM ET

    Register

Replays

  • Taysha Gene Therapies (NASDAQ:TSHA) Q2 2026 Earnings Call

    Tue, Aug 11, 2026 · 4:30 PM ET

    Watch Transcript

  • Taysha Gene Therapies (NASDAQ:TSHA) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 8:30 AM ET

    Watch Transcript

  • Taysha Gene Therapies (NASDAQ:TSHA) Q4 2025 Earnings Call

    Thu, Mar 19, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nov 6, 2026

Closed $4.33 (+5.9%) on Nov 6, 2026

Taysha Gene Therapies to Release Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 12

Nov 5, 2026

Closed $4.09 (-6.2%) on Nov 5, 2026

Taysha Gene Therapies Announces Inducement Grant under Nasdaq Listing Rule 5635(4)

Oct 5, 2026

Closed $4.49 (-3.0%) on Oct 5, 2026

Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting

Oct 1, 2026

Closed $4.74 (-2.7%) on Oct 1, 2026

Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Aug 11, 2026

Closed $6.41 (-4.1%) on Aug 12, 2026

Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11

Aug 4, 2026

Closed $6.46 (+4.2%) on Aug 5, 2026

Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome

Aug 3, 2026

Closed $5.78 (-1.4%) on Aug 3, 2026

Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting

Jun 25, 2026

Closed $6.34 (+2.1%) on Jun 26, 2026

Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome

Jun 22, 2026

Closed $6.53 (+1.7%) on Jun 22, 2026

Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 6, 2026

Closed $6.98 (+0.6%) on May 6, 2026

All Taysha Gene Therapies, Inc. news

Financings

  • Public offering of shares

    Aug 12, 2025

    Closed: US$230M raised · US$2.75 a share · Jefferies +3

    Dealers: Jefferies (co-lead), BofA Securities (co-lead), Piper Sandler (co-lead), Barclays (co-lead)

    Use of proceeds: Strengthen balance sheet and extend cash runway into 2028

    Announced May 28, 2025 · Closed Aug 12, 2025

Read by 6ix AI from the company's releases

Decks

Taysha Gene Therapies, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
15 in the last 12 months · 171 in all · newest Nov 6, 2026 · oldest 2020
Calls
21 calls with a replay · 21 with a transcript · latest Aug 11, 2026
Decks
9 decks · latest August 2026

Where Taysha Gene Therapies, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TSHA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:TSHABOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Taysha Gene Therapies, Inc.